Real-world drug survival of ixekizumab for psoriasis - 21/06/19
Doi : 10.1016/j.jaad.2019.01.034
Erica B. Lee, BS a, Deeti J. Pithadia, BS b, Kelly A. Reynolds, BA c, Shivani P. Reddy, MD d, Alexander Egeberg, MD, PhD e, Jashin J. Wu, MD f, ⁎ 
a University of Hawaii, John A. Burns School of Medicine, Honolulu, Hawaii
b Medical College of Georgia, Augusta University, Augusta, Georgia
c University of Cincinnati, College of Medicine, Cincinnati, Ohio
d Kaiser Permanente Los Angeles Medical Center, Department of Dermatology, Los Angeles, California
e Herlev and Gentofte Hospital, Department of Dermatology and Allergy, University of Copenhagen, Hellerup, Denmark
f Dermatology Research and Education Foundation, Irvine, California
∗Reprint requests: Jashin J. Wu, MD
| Funding sources: None. |
|
| Disclosure: Dr Wu is an investigator for AbbVie, Amgen, Eli Lilly, Janssen, and Novartis; a consultant for AbbVie, Almirall, Amgen, Bristol-Myers Squibb, Celgene, Dermira, Dr. Reddy's Laboratories, Eli Lilly and Company, Janssen, LEO Pharma, Novartis, Ortho Dermatologics, Promius Pharma, Regeneron, Sun Pharmaceutical, and UCB; and a speaker for Celgene, Novartis, Sun Pharmaceutical, and UCB. Dr Egeberg has received research funding from Pfizer, Eli Lilly and Company, the Danish National Psoriasis Foundation, and the Kgl Hofbundtmager Aage Bang Foundation, and he as received honoraria as a consultant and/or speaker from Almirall, Leo Pharma, Samsung Bioepis Co, Ltd., Pfizer, Eli Lilly and Company, Novartis, Galderma, Dermavant, Bristol-Myers Squibb, and Janssen Pharmaceuticals. Ms Lee, Ms Pithadia, Ms Reynolds, and Dr Reddy have no conflicts of interest to disclose. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 81 - N° 1
P. 270-272 - juillet 2019 Retour au numéro
Article précédent
- The most common causes of burnout among US academic dermatologists based on a survey study
- Deborah N. Dorrell, Steven R. Feldman, William Wei-ting Huang
- Secukinumab drug survival in patients with psoriasis: A multicenter, real-world, retrospective study
- Tiago Torres, Anna Balato, Curdin Conrad, Andrea Conti, Paolo Dapavo, Paulo Ferreira, Francesca Gaiani, Luíz Leite, Piergiorgio Malagoli, Pedro Mendes-Bastos, Matteo Megna, Francesco Messina, Alessia Nidegger, Giulia Odorici, Stefano Piaserico, Francesca Prignano, Simone Ribero, Federica Ricceri, Annalisa Tonini, Joana Valério, Andrea Chiricozzi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?